GCTK

Glucotrack, Inc. GCTK

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 19 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$187.1K total
HRT FINANCIAL LP
$65.0K+405.6%
JANE STREET GROUP, LLC
$41.0KNew
CITADEL ADVISORS LLC
$25.4KNew
Ikarian Capital, LLC
$14.6K0.0%
GEODE CAPITAL MANAGEMENT, LLC
$10.9K-27.2%
Virtu Financial LLC
$6.0KNew
GRANITE ISLANDS PRIVATE WEALTH, LLC
$5.0KNew
BOOTHBAY FUND MANAGEMENT, LLC
$4.3K0.0%
UBS Group AG
$4.3K+1800.7%
CITIGROUP INC
$4.1KNew
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$3.4KNew
ALERUS FINANCIAL NA
$1.3K0.0%
Tower Research Capital LLC (TRC)
$1.1K0.0%
BARCLAYS PLC
$402New
PlanVest Financial, Inc
$319New
Tradewinds Capital Management, LLC
$16New
Newbridge Financial Services Group, Inc.
$110.0%
SBI Securities Co., Ltd.
$30.0%
OSAIC HOLDINGS, INC.
$00.0%
See all 19 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/GCTK

Earnings Per Share

13fpro.ai/company/GCTK

Loading ratio trend…

GCTK key financials by period

Reported revenue, net income and operating margin by fiscal year, from Glucotrack, Inc.'s annual filings on SEC EDGAR.

Glucotrack, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2019$208.0K$3.5M—
FY 2018$17.0B$-6.7M-0.0%
FY 2017$589.5K$10.3M—
FY 2016$611.7K$-5.4M—
FY 2015$143.2K$-5.8M—
FY 2014$59.8K$3.0M—
Source: GCTK filings on SEC EDGAR →

About Glucotrack, Inc. (GCTK): stock profile, AI score and financials

Glucotrack, Inc. (GCTK) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. GCTK is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 19 institutional filers currently hold this stock. Top institutional holders of GCTK by reported 13-F value include HRT FINANCIAL, JANE STREET GROUP, CITADEL ADVISORS, based on the most recent SEC filings. GCTK trades on the Nasdaq exchange and files with the SEC under CIK 1506983. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GCTK daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Glucotrack, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1506983 →